|Year : 2016 | Volume
| Issue : 45 | Page : 31-35
Nuclear factor kappa B activation and peroxisome proliferator-activated receptor transactivational effects of chemical components of the roots of Polygonum multiflorum
Ya Nan Sun1, Wei Li2, Seok Bean Song3, Xi Tao Yan4, Seo Young Yang1, Young Ho Kim1
1 College of Pharmacy, Chungnam National University, Daejeon 305-764, Korea
2 School of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk 712-749, Korea
3 Gyeongbuk Institute for Bio-industry, Andong City, Gyeongbuk 760-380, Korea
4 College of Pharmacy, Korea University, Sejong 339-700, Korea
|Date of Web Publication||10-Feb-2016|
Young Ho Kim
College of Pharmacy, Chungnam National University, Daejeon 305-764
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Polygonum multiflorum is well-known as "Heshouwu" in traditional Chinese herbal medicine. In Northeast Asia, it is often used as a tonic to prevent premature aging of the kidney and liver, tendons, and bones and strengthening of the lower back and knees. Objective: To research the anti-inflammatory activities of components from P. multiflorum. Materials and Methods: The compounds were isolated by a combination of silica gel and YMC R-18 column chromatography, and their structures were identified by analysis of spectroscopic data (1D, 2D-nuclear magnetic resonance, and mass spectrometry). The anti-inflammatory activities of the isolated compounds 1−15 were evaluated by luciferase reporter gene assays. Results: Fifteen compounds (1-15) were isolated from the roots of P. multiflorum. Compounds 1−5 and 14−15 significantly inhibited tumor necrosis factor-α-induced nuclear factor kappa B-luciferase activity, with IC 50 values of 24.16-37.56 μM. Compounds 1−5 also greatly enhanced peroxisome proliferator-activated receptors transcriptional activity with EC 50 values of 18.26−31.45 μM. Conclusion: The anthraquinone derivatives were the active components from the roots of P. multiflorum as an inhibitor on inflammation-related factors in human hepatoma cells. Therefore, we suggest that the roots of P. multiflorum can be used to treat natural inflammatory diseases.
Keywords: Human hepatoma cells, nuclear factor kappa B, peroxisome proliferator-activated receptors, Polygonaceae, Polygonum multiflorum
|How to cite this article:|
Sun YN, Li W, Song SB, Yan XT, Yang SY, Kim YH. Nuclear factor kappa B activation and peroxisome proliferator-activated receptor transactivational effects of chemical components of the roots of Polygonum multiflorum. Phcog Mag 2016;12:31-5
|How to cite this URL:|
Sun YN, Li W, Song SB, Yan XT, Yang SY, Kim YH. Nuclear factor kappa B activation and peroxisome proliferator-activated receptor transactivational effects of chemical components of the roots of Polygonum multiflorum. Phcog Mag [serial online] 2016 [cited 2022 Jun 26];12:31-5. Available from: http://www.phcog.com/text.asp?2016/12/45/31/176019
- This study presented that fifteen compounds (1-15) isolated from the roots of Polygonum multiflrum exert signifiant anti inflmmatory effects by inhibiting TNF induced NF B activation and PPARs transcription.
| Introduction|| |
Nuclear factor kappa B (NF-κB) is a protein complex that controls DNA transcription. This complex comprises a family of structurally related eukaryotic transcription factors that promote the expression of over 150 genes involved in a variety of cellular processes. , It is found in nearly all animal cell types and is involved in several cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, and bacterial or viral antigens. ,,, Five members of the NF-κB family (p50, p52, p65/Rel A, c-Rel, and Rel B) form 15 transcription factors through homo- and hetero-dimerization. , In the previous study, NF-κB was determined to play an important role in the transcriptional regulation of numerous cytokines and adhesion molecules. It is the most extensively studied transcription factor in the immune system.  Furthermore, in most cell types, inactive NF-κB complexes are sequestered in the cytoplasm via noncovalent interactions with inhibitory proteins known as inhibitor kappa B. Therefore, activation of NF-κB causes transcription at the κB site, which is involved in several diseases including inflammatory disorders and cancer. Hence, inhibition of NF-κB signaling is an important therapeutic target for the treatment of such diseases. 
Peroxisome proliferator-activated receptors (PPARs) is a member of the nuclear receptor superfamily as transcription factors regulating the expression of genes.  It plays essential roles in the regulation of cellular metabolism, inflammatory, and immune responses. There are three isoforms: PPARα, PPARβ, and PPARγ have been identified. PPARs regulate the expression of genes involved in the regulation of glucose, lipid, and cholesterol metabolism by binding to specific peroxisome proliferator response elements (PPREs) in the enhancer sites of regulated genes. ,, Accordingly, modulate the function of PPARs are attractive for the treatment of tissues with high catabolic rates for fatty acids and peroxisome metabolism, and it has become a target for the prevention and treatment of obesity, insulin resistance, metabolic syndromes, inflammation, and cardiovascular disease.  In the present study, the effects of compounds 1-15 from Polygonum multiflorum on tumor necrosis factor-α (TNF-α) induced NF-κB transcriptional activity and PPARs transcriptional activity were evaluated in human hepatocarcinoma human hepatoma cells (HepG2) cells.
P. multiflorum belongs to the Polygonaceae family, is one of the most important traditional Chinese herbs, and listed in the official Chinese Pharmacopeia. It has long been used in the preparation of herbal medicines in many oriental countries such as China, Japan, and Korea.  This herb exerts many significant effects, such as antioxidant, and antitumor properties, improves cardiovascular symptoms, enhances immune function, reduces cholesterol, and inhibits atherosclerosis. , P. multiflorum root extracts and some monomeric compounds isolated from P. multiflorum roots were reported to exert anti-inflammatory,  antioxidant,  anti-HIV,  and liver protective effects.  However, the effects of chemical components from P. multiflorum on NF-κB and PPARs transcriptional inhibitory activity have not yet been reported. In the present study, fifteen compounds were isolated from the roots of P. multiflorum and their anti-inflammatory activities were evaluated to determine their therapeutic potential.
| Materials and Methods|| |
General experimental procedures
Optical rotations were determined using a Jasco DIP-370 automatic polarimeter. The Fourier Transform Infrared spectra were measured using a Jasco Report-100 infrared spectrometer. The nuclear magnetic resonance spectra were recorded using a JEOL ECA 600 spectrometer ( 1 H, 600 MHz; 13 C, 150 MHz). Electrospray ionization mass spectrometry was recorded using an Agilent 1200 LC MSD trap spectrometer. Column chromatography was performed using a silica gel (Kieselgel 60, 70-230, and 230-400 mesh, Merck, Darmstadt, Germany), YMC RP-18 resins, and thin layer chromatography was performed using precoated silica-gel 60 F 254 and RP-18 F 254S plates (both 0.25 mm, Merck, Darmstadt, Germany); the spots were detected under ultraviolet light and using 10% H 2 SO 4 .
Dried roots of P. multiflorum were purchased from the herbal company, Naemome Dah, Ulsan, Korea, in November 2011, and identified by Prof. Young Ho Kim, College of Pharmacy, Chungnan National University. A voucher specimen (CNU11103) was deposited at the herbarium of the College of Pharmacy, Chungnam National University in Korea.
Extraction and isolation
Dried roots of P. multiflorum (3.0 kg) were extracted with 70% EtOH 3 times under refluxing. The 70% EtOH extract (500.0 g) was suspended in H 2 O (2.8 L) and partitioned with CH 2 Cl 2 and EtOAc to yield CH 2 Cl 2 fraction (a), EtOAc fraction (b), aqueous fraction (c), respectively. The CH 2 Cl 2 extract (14.0 g) was subjected to silica gel column chromatography with a gradient of n-hexane-EtOAc (25:1-0:1) to give five fractions (A1-A5). Fraction A3 was further chromatographed on a silica gel column using a gradient of n-hexane-EtOAc (6:1-0:1) to give three subfractions (A3.1-A3.3), then subfraction A3.3 was chromatographed on a silica gel column with n-hexane-EtOAc (3:1-1:5) to obtain four subfractions (A3.3.1-A3.3.4), further purification of the subfraction A3.3.2 and A3.3.4 led to compounds 1 (20.0 mg) and 2 (917.3 mg). Fraction A5 was column chromatographed over silica gel, eluting with CH 2 Cl 2 -MeOH (10:1-1:1) to provide six subfractions (A5.1-A5.6), then subfraction A5.4 was further chromatographed on a reverse-phase (RP) chromatography column with MeOH-H 2 O (1:1-2.5:1) to give compounds 3 (5.0 mg), 14 (39.0 mg), and 15 (53.0 mg). The EtOAc extract (103.0 g) was chromatographed over silica gel column with a gradient of CH 2 Cl 2 -MeOH (20:1-1:1) to yield 4 fractions (B1-B4). Fraction B1 was chromatographed on a silica gel chromatography column with CH 2 Cl 2 -MeOH (50:1-5:1) to yield 6 subfractions (B1.1-B1.6); subfraction B1.2 was further chromatographed on RP chromatography column with acetone-MeOH-H 2 O (0.2:0.5:1) to yield compounds 12 (210.0 mg) and 13 (40.0 mg). Subfraction B1.4 was separated by a RP chromatography column using acetone-MeOH-H 2 O (0.2:0.5:1-1:1:1) as eluents, further purified by chromatography column over silica gel, to obtain compounds 4 (75.0 mg), 6 (17.0 mg), 7 (180.0 mg), 10 (35.0 mg), and 11 (52.0 mg). Compounds 5 (13.0 mg), 8 (290.0 mg), and 9 (28.0 mg) were isolated from fraction B1.5 using a RP chromatography column with MeOH-H 2 O (1:5-2:1).
Cell culture and reagents
HepG2 cells were maintained in Dulbecco's modified Eagles' medium (DMEM) (Invitrogen, Carlsbad, CA, USA) containing 10% heat-inactivated fetal bovine serum (FBS), 100 units/mL penicillin, and 10 μg/mL streptomycin at 37°C and 5% CO 2 . Human TNF-α was purchased from ATgen (Seoul, Korea).
A cell-counting kit (CCK)-8 (Dojindo, Kumamoto, Japan) was used to analyze the effect of compounds on cell toxicity according to the manufacturer's instructions. HepG2 cells were cultured overnight in a 96-well plate (∼1 × 10 4 cells/well). Cell toxicity was assessed after the addition of compounds in a dose-dependent manner. After 24 h of the treatment, 10 μL of the CCK-8 solution was added to triplicate wells and incubated for 1 h. The absorbance at 450 nm was measured to determine the viable cell numbers.
Nuclear factor kappa B-luciferase assay
The luciferase vector was first transfected into human hepatocarcinoma HepG2 cells. After a limited amount of time, the cells were lysed, and luciferin, the substrate of luciferase, was introduced into the cellular extract along with Mg 2+ and an excess of ATP. Under these conditions, luciferase enzymes expressed by the reporter vector could catalyze the oxidative carboxylation of luciferin. Cells were seeded at 2 × 10 5 cells per well in 12-well plates and grown. After 24 h, cells were transfected with inducible NF-κB luciferase reporter and constitutively expressing Renilla reporter. After 24 h of transfection, medium was changed to assay medium (Opti-MEM + 0.5% FBS + 0.1 mM NEAA + 1 mM sodium pyruvate + 100 units/mL penicillin + 10 μg/mL streptomycin), and cells were pretreated for 1 h with either vehicle (dimethyl sulfoxide [DMSO]) and compounds, followed by 1 h of treatment with 10 ng/mL TNF-α for 20 h. Unstimulated cells were used as a negative control (−); apigenin was used as a positive control. Dual luciferase assay was performed 48 h after transfection, and promoter activity values are expressed as arbitrary units using a Renilla reporter for internal normalization.
Peroxisome proliferator response elements-luciferase assay
HepG2 were seeded at 1.5 × 10 5 cells per well in 12-well plates and grown for 24 h before transfection. An optimized amount of DNA plasmid (0.5 μg of PPRE-Luc and 0.2 μg of PPAR-inpCMV) was diluted in 100 μL of DMEM. All cells were transfected with the plasmid mixture using WelFect M Gold (WelGENE Inc.) as described by the manufacturer. After 30 min of incubation at room temperature, the DNA plasmid solution (100 μL) was introduced and mixed gently with cells. After 24 h of transfection, the medium was changed to (transfection optimized medium, Invitrogen) containing 0.1 mM NEAA, 0.5% charcoal-stripped FBS, and the individual compounds (test group), DMSO (vehicle group), or rosiglitazone (positive control group). The cells were then cultured for 20 h. Next, the cells were washed with PBS and harvested with 1 × passive lysis buffer (200 μL). The intensity of emitted luminescence was determined using an LB 953 Autolumat (EG and G Berthold, Bad Wildbad, Germany).
All measurements were performed independently at least triplicate. Data were expressed as the mean ± standard deviation. Statistical significance is determined by one-way analysis of variance followed by Dunnett's multiple comparison test P < 0.05.
| Results and Discussion|| |
In the current study, five anthraquinones (1-5), two torachrysones (6 and 7), four stilbene glycosides (8-11), two flavanols (12 and 13), and two sterols (14 and 15) were isolated from methanol extracts of P. multiflorum roots [Figure 1]. Their structures were elucidated by comparing spectroscopic data to published data. The compounds were identified as follows: Physcion (1),  emodin (2),  physcion-8-O-β-D-(6'-O-acetyl)-glucoside (3),  emodin- 8-O-β-D-glucoside (4),  physcion-8-O-β-D-glucoside (5),  torachrysone-8-O-β-D-glucoside (6),  torachrysone-8-O-β-D-glucoside-6'-O-gallate (7),  (Z)-2, 3, 5, 4'- tetrahydroxystilbene-2-O-β-D-glucoside (8),  (E)-2, 3, 5, 4'-tetrahydroxystilbene-2-O-β-D-glucoside (9),  (E)-2, 3, 5, 4'- tetrahydroxystilbene-2-O-β-D-xyloside (10),  (E)-2, 3, 5, 4'- tetrahydroxystilbene-2-O-β-D-(6'-O-acetyl)-glucoside (11),  (+)- catechin (12),  (+)-catechin-3-O-gallate (13),  β-sitosterol (14),  and β-sitosterol-3-O-β-D-glucoside (15). 
|Figure 1: Structures of compounds 1-15 from the roots of Polygonum multiflorum|
Click here to view
Compounds 1−15 were evaluated for cytotoxicity according to the manufacturer's instructions using a CCK-8 (Dojindo, Kumamoto, Japan) assay, as described in "Materials and Methods." Results indicated that compounds 1−15 caused no significant cytotoxicity in HepG2 cells at the tested concentrations [Figure 2].
|Figure 2: Cytotoxic effects of compounds 1-15 on human hepatoma cells all values are means ± standard deviation (n = 3,/P < 0.05). Dimethyl sulfoxide as control group. human hepatoma cells 2 were cultured overnight in 96-well plates and treated with 10 µM for 24 h. Cell viability was assessed using MTS assays. The results are expressed in terms of percentage relative cell viability|
Click here to view
HepG2 cells were treated with 10 ng/mL TNF-α, which resulted in increased transcriptional activity relative to untreated cells. Transfected HepG2 cells were pretreated with 0.1, 1, and 10 μM of each compound, followed by stimulation with TNF-α [Figure 3]. Apigenin was used as a positive control (IC 50 : 1.64 ± 0.19). The anti-inflammatory activities of compounds 1−15 were evaluated by the inhibition of a TNF-α-induced NF-κB luciferase reporter in HepG2 cells. Compounds 1−5 and 14−15 significantly inhibited TNF-α-induced NF-κB transcriptional activity, with IC 50 values of 30.25, 25.63, 37.56, 24.16, 25.71, 28.78, and 31.56 μM, respectively. In contrast, compound 8 exhibited weak inhibitory activity, with an IC 50 value of 50.20 μM. We continuously investigated the effects of compounds 1-15 on PPAR activity using a nuclear transcription PPRE cell-reporter system. HepG2 cells were treatment with 0.1, 1, and 10 μM of compounds, The results showed that compounds 1−5 greatly enhanced PPARs transcriptional activity with EC 50 values of 18.26−31.45 μM [Table 1], whereas compounds 6-15 were inactive (EC 50 >50 μM).
|Figure 3: Effects of compounds 1 − 15 on the tumor necrosis factor-α induced nuclear factor kappa B-luciferase reporter activity in human hepatoma cells. The values are means ± standard deviations (n = 3). Apigenin, positive control (10 μM). Statistical significance is determined by one-way analysis of variance followed by Dunnett's multiple comparison test, P < 0.05 versus control|
Click here to view
Consistent with the structure-activity relationship of the isolated compounds (1-15), the anthraquinone derivatives (1-5) exerted significant effect inhibitory activities on NF-κB transcription, with IC 50 values of 24.16-37.56 μM. In addition, the sterol derivatives (14 and 15) also displayed potent inhibitory activities, with IC 50 values of 28.78 and 31.56 μM. These results indicate that the anthraquinone and sterol derivative components from P. multiflorum may play an important role in TNF-α induced NF-κB transcriptional activity. Compared with compounds 9−11, compound 8 is a cis-form stilbene glycoside that displays obvious NF-κB inhibitory activity at the same concentration, suggesting that all cis-form stilbene glycosides exhibit increased NF-κB transcriptional inhibitory activity. Moreover, the anthraquinone derivatives (1−5) exerted obvious activated PPAR transcriptional activity in a dose-dependent manner. Other compounds (6−15) did not exhibit significant activity. It suggests that anthraquinone derivatives from P. multiflorum are the active ingredient for activation of PPAR transcription. These results may be useful for determining the structure − function relationship of the useful components of P. multiflorum.
| Conclusion|| |
These results led us to conclude that fifteen compounds (1-15) isolated from the roots of P. multiflorum exert significant anti-inflammatory effects by inhibiting TNF-α induced NF-κB activation and PPARs transcription. Interestingly, the results of this study indicate that anthraquinone and sterol derivatives of P. multiflorum exhibit strong anti-inflammatory activities by inhibiting TNF-α induced NF-κB activation; anthraquinone derivatives from P. multiflorum are activated PPAR transcription. Therefore, we suggest that the roots of P. multiflorum can be used to treat natural inflammatory diseases. However, further studies on potential anti-inflammatory effects and benefits of anthraquinone, sterol, and stilbene derivative components from P. multiflorum are warranted.
This study was supported by the Priority Research Center Program (2009-0093815) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, Republic of Korea.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-60.
Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-66.
Gilmore TD. The Rel/NF-kappaB signal transduction pathway: Introduction. Oncogene 1999;18:6842-4.
Gilmore TD. Introduction to NF-kappaB: Players, pathways, perspectives. Oncogene 2006;25:6680-4.
Brasier AR. The NF-kappaB regulatory network. Cardiovasc Toxicol 2006;6:111-30.
Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49-62.
Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2:725-34.
Senftleben U, Karin M. The IKK/NF-kappa B pathway. Crit Care Med 2002;30 1 Suppl: S18-26.
Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 2006;210:171-86.
Kim MS, Kim SH. Studies on the constituents of the stem bark of Kalopanax pictus
. Arch Pharm Res 2011;39:2101-7.
Clark RB. The role of PPARs in inflammation and immunity. J Leukoc Biol 2002;71:388-400.
Cabrero A, Laguna JC, Vázquez M. Peroxisome proliferator-activated receptors and the control of inflammation. Curr Drug Targets Inflamm Allergy 2002;1:243-8.
Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 1999;20:649-88.
Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996;137:354-66.
Haluzík MM, Haluzík M. PPAR-alpha and insulin sensitivity. Physiol Res 2006;55:115-22.
Chen LL, Huang XJ, Li MM, Ou GM, Zhao BX, Chen MF, et al
. Polygonflavanol A, a novel flavonostilbene glycoside from the roots of Polygonum multiflorum
. Phytochem Lett 2012;5:756-60.
Lv LS, Gu XH, Tang J, Ho CT. Antioxidant activity of stilbene glycoside from Polygonum multiflorum
Thunb in vivo
. Food Chem 2007;104:1678-81.
Thiruvengadam M, Praveen N, Kim EH, Kim SH, Chung IM. Production of anthraquinones, phenolic compounds and biological activities from hairy root cultures of Polygonum multiflorum
Thunb. Protoplasma 2014;251:555-66.
Zhang YZ, Shen JF, Xu JY, Xiao JH, Wang JL. Inhibitory effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside on experimental inflammation and cyclooxygenase 2 activity. J Asian Nat Prod Res 2007;9:355-63.
Chen Y, Wang M, Rosen RT, Ho CT. 2,2-Diphenyl-1-picrylhydrazyl radical-scavenging active components from Polygonum multiflorum
thunb. J Agric Food Chem 1999;47:2226-8.
Lin HW, Sun MX, Wang YH, Yang LM, Yang YR, Huang N, et al.
Anti-HIV activities of the compounds isolated from Polygonum cuspidatum
and Polygonum multiflorum
. Planta Med 2010;76:889-92.
Wang M, Zhao R, Wang W, Mao X, Yu J. Lipid regulation effects of Polygoni Multiflori Radix, its processed products and its major substances on steatosis human liver cell line L02. J Ethnopharmacol 2012;139:287-93.
Choi SG, Kim J, Sung ND, Son KH, Cheon HG, Kim KR, et al.
Anthraquinones, Cdc25B phosphatase inhibitors, isolated from the roots of Polygonum multiflorum
Thunb. Nat Prod Res 2007;21:487-93.
Kim YM, Lee CH, Kim HG, Lee HS. Anthraquinones isolated from Cassia tora
(Leguminosae) seed show an antifungal property against phytopathogenic fungi. J Agric Food Chem 2004;52:6096-100.
Qi HY, Zhang CF, Zhang M. Three new anthraquinones from Polygonum cillinerve
. Chin Chem Lett 2005;16:1050-2.
Kwon BM, Kim SH, Baek NI, Lee SI, Kim EJ, Yang JH, et al.
Farnesyl protein transferase inhibitory components of Polygonum multiflorum
. Arch Pharm Res 2009;32:495-9.
Zhang H, Guo Z, Wu N, Xu W, Han L, Li N, et al.
Two novel naphthalene glucosides and an anthraquinone isolated from Rumex dentatus
and their antiproliferation activities in four cell lines. Molecules 2012;17:843-50.
Sun YN, Cui L, Li W, Yan XT, Yang SY, Kang JI, et al.
Promotion effect of constituents from the root of Polygonum multiflorum
on hair growth. Bioorg Med Chem Lett 2013;23:4801-5.
Kim HK, Choi YH, Choi JS, Choi SU, Kim YS, Lee KR, et al.
A new stilbene glucoside gallate from the roots of Polygonum multiflorum
. Arch Pharm Res 2008;31:1225-9.
Kashiwada Y, Nonaka GI, Nishioka I. Tannins and related compounds. XLV. Rhubarb. Isolation and characterization of flavan-3-ol and procyanidin glucosides. Chem Pharm Bull 1986;34:3208-22.
Ma J, Yang H, Basile MJ, Kennelly EJ. Analysis of polyphenolic antioxidants from the fruits of three Pouteria
species by selected ion monitoring liquid chromatography-mass spectrometry. J Agric Food Chem 2004;52:5873-8.
[Figure 1], [Figure 2], [Figure 3]
|This article has been cited by|
||Anti-inflammation of torachrysone-8-O-ß-?-glucoside by hurdling over morphological changes of macrophages
| ||Wenlong Zhao, Di Xu, Lin Zhang, Huihui Meng, Qi Zheng, Junsong Wang |
| ||International Immunopharmacology. 2022; 105: 108548 |
|[Pubmed] | [DOI]|
||Treatment-Refractory Central Centrifugal Cicatricial Alopecia Responsive to a Novel Botanical Treatment
| ||Sanusi Umar, Petrina Kan, Marissa J Carter, Paul Shitabata |
| ||Clinical, Cosmetic and Investigational Dermatology. 2022; Volume 15: 609 |
|[Pubmed] | [DOI]|
||A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix
| ||Mengting Zhou, Naihua Hu, Meichen Liu, Ying Deng, Linfeng He, Chaocheng Guo, Xingtao Zhao, Yunxia Li |
| ||BioMed Research International. 2020; 2020: 1 |
|[Pubmed] | [DOI]|
||A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines
| ||Ming Hong,Sha Li,Hor Tan,Fan Cheung,Ning Wang,Jihan Huang,Yibin Feng |
| ||Molecules. 2017; 22(4): 632 |
|[Pubmed] | [DOI]|
||Design and Syntheses of Novel Fluoroporphyrin–Anthraquinone Complexes as Antitumor Agents
| ||Gu-Liang Yang,Sheng-Fang Zhao,Nian-You Chen,Shiming Li |
| ||CHEMICAL & PHARMACEUTICAL BULLETIN. 2016; 64(9): 1310 |
|[Pubmed] | [DOI]|